BeatO, a health-tech start up in India, has raised Rs 11.75 crore in its Pre-Series A round – led by Orios Venture Partners with participation from existing investors -Blume Ventures, Leo Capital and Vishal Sampat.
It had previously raised a seed fund from Blume Ventures and Leo Capital in 2017.
Delhi-based BeatO focuses on meeting the needs of a person with diabetes. The consumer starts to use BeatO by purchasing their smartphone -based glucometer that connects with the mobile app. The BeatO Glucometer connects to the user’s smartphone and works with the BeatO app.
The tech start-up will utilize the funds to increase its user base and revenue, which have grown 10x over the last 12 months and expand the product line for its flagship glucometer and FMCG/retail categories.
The team will be investing in R&D, platform upgradation for auto-suggestions basis blood sugar readings and product development in order to come up with new and innovative products and services for its ecosystem, said Gautam Chopra, co-founder of BeatO.
Anup Jain, managing partner at Orios Venture Partners and Arpit Agarwal, principal at Blume Ventures were instrumental in the VC funding of BeatO.
Gautam Chopra and Yash Sehgal founded BeatO in 2015. BeatO serves 50,000 diabetic customers in more than 1,500 cities and is currently fulfilling over 15,000 transactions a month.
